Cargando…
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
The endocannabinoid anandamide (AEA) causes vasorelaxation in animal studies. Although circulating AEA levels are increased in many pathologies, little is known about its vascular effects in humans. The aim of this work was to characterise the effects of AEA in human arteries. Ethical approval was g...
Autores principales: | Stanley, Christopher P., Hind, William H., Tufarelli, Christina, O’Sullivan, Saoirse E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113919/ https://www.ncbi.nlm.nih.gov/pubmed/27633407 http://dx.doi.org/10.1016/j.phrs.2016.08.028 |
Ejemplares similares
-
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB(1) activation
por: Stanley, Christopher P., et al.
Publicado: (2015) -
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
por: Wheal, Amanda J., et al.
Publicado: (2017) -
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
por: Smith, Marie, et al.
Publicado: (2015) -
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2014) -
Reduced Endothelium-Dependent Relaxation to Anandamide in Mesenteric Arteries from Young Obese Zucker Rats
por: Lobato, Nubia S., et al.
Publicado: (2013)